Kyrgyzstan Medical Device Registration: Simplified Procedure for Devices Cleared in Eight Reference Countries

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

For devices that already hold current, valid registration documents in one of eight jurisdictions: the European Union, Australia, the United Kingdom, Canada, the United States, Switzerland, Norway and Japan, Kyrgyzstan operates a simplified national registration channel. Its economic value is twofold: certain technical documents may be omitted, including the list of conformity standards, protocols of efficacy and safety testing, clinical trial reports, storage stability test reports, and documents on incorporated medicinal products, sterilization and software, and the review timeline is shortened at the same time. A draft amendment released for public consultation by the responsible authority in 2026 goes further, proposing to compress the channel timeline from the current maximum of 30 calendar days to 10 working days (draft status, not yet in force).

2. Legal basis

  1. Cabinet Resolution No. 513, August 27, 2024, Annex 1 (simplified national registration procedure).
  2. Article 14 of Law No. 216: foreign products must be confirmed as circulating as medical devices in the country of manufacture or another country, and must obtain a favorable expert opinion.
  3. Draft amendment released for public consultation by the Ministry of Health of the Kyrgyz Republic in 2026 (to amend Cabinet Resolution No. 513):
    • For devices holding registration documents from the eight jurisdictions, the registration timeline would be compressed from the current maximum of 30 calendar days (counted from confirmation of fee payment) to 10 working days;
    • The compression would be achieved by merging the dossier completeness check and the issuance of the payment invoice, and by accelerating decision approval and entry into the national register;
    • Registration certificates would be issued in electronic format;
    • For devices without certificates from the eight jurisdictions that require a manufacturing inspection, favorable manufacturing inspection reports issued by competent authorities of other union member states would be recognized, with confirmation from at least two member states required.
    • All of the above is in draft status and not yet in force.
  4. Multilateral organization country study report (Japan International Cooperation Agency, November 2025): Cabinet Resolution No. 513 simplifies registration for devices already registered in the EU, Australia, the United Kingdom, Canada, the United States, Switzerland, Norway or Japan, which are exempt from the designated documents listed above.

3. Expert insights

Insight one: the simplified channel waives duplicate proof, not the obligation to prove.

The five categories of documents that may be omitted share one feature: their content has already been reviewed once by a competent authority in one of the eight jurisdictions. Kyrgyzstan waives the duplicate review, not the underlying requirement. Companies must still provide an index and summary of these documents so that national experts can judge whether the foreign certificate and the declared product match in models, specifications, manufacturing sites and intended use.

Insight two: consistency is the implicit threshold of the simplified channel.

The product covered by the foreign certificate and the product declared in Kyrgyzstan must align on all key dimensions. If the certificate covers a narrower model range than the declaration, or the manufacturing site differs, or the intended use wording diverges, the usability of the simplified channel is compromised. We recommend building a certificate-to-declaration comparison table at project launch and checking item by item: product name and models, manufacturing site, intended use, key performance parameters, sterilization method and software version.

Insight three: the two-state confirmation mechanism in the draft opens a window for companies without eight-jurisdiction certificates.

The draft also proposes that devices without certificates from the eight jurisdictions that require a manufacturing inspection may submit favorable manufacturing inspection reports issued by competent authorities of other union member states, with confirmation from at least two member states. For Chinese manufacturers the significance is clear: if a company has already completed a manufacturing inspection under the union framework in Russia or Kazakhstan, that investment may not need to be repeated in Kyrgyzstan. Existing inspection reports should be organized in advance and their usability assessed once the mechanism takes effect (draft status).

Insight four: the shift to electronic certificates will change post-certificate management.

The draft proposes issuing registration certificates in electronic format. This looks like a technical change but has practical consequences: verification of paper certificates, archiving of copies, and the process by which customers request certificate originals will all change. Companies should adjust internal document management and customer response processes ahead of time (draft status).

Insight five: the difference between 30 calendar days and 10 working days must be converted before comparison.

Thirty calendar days is roughly 4.3 weeks; ten working days is 2 weeks. The compression is nearly half, but both figures start from confirmation of fee payment: document preparation, the completeness check and the issuance of the payment invoice before payment are excluded. When committing launch dates externally, companies must not treat these two numbers as the total project duration.

4. Practical recommendations

First, complete the certificate comparison table at the project definition stage. Before committing to the simplified channel, run an item-by-item comparison of the eight-jurisdiction certificate against the declared product across six dimensions: models and specifications, manufacturing site, intended use, key performance parameters, sterilization method and software version. Where the comparison fails, decide early whether to expand the certificate coverage or switch to the standard procedure.

Second, prepare an index and summary even for waived documents. We recommend including a certificate coverage statement in the dossier even when documents may be omitted, listing the waived documents, the numbers and validity dates of the eight-jurisdiction certificates, and the mapping between the certificate and the declared product. This statement measurably reduces review back-and-forth.

Third, track the draft but do not schedule against it. Both the 10 working days and the electronic certificate remain at draft stage. Base the project plan on the current 30 calendar days and treat the draft taking effect as an upside scenario for timeline optimization, never the reverse.

Fourth, organize existing manufacturing inspection reports from the union framework. Record the issuing authority, date, scope and conclusions, and assess whether the requirement of confirmation from at least two member states can be met. This material converts directly into time savings once the draft takes effect.

5. Verification checklist

  • □ Confirm whether a current, valid registration document is held in one of the eight jurisdictions: the EU, Australia, the United Kingdom, Canada, the United States, Switzerland, Norway, Japan;
  • □ Complete the six-dimension comparison of the eight-jurisdiction certificate against the declared product: name and models, manufacturing site, intended use, key performance parameters, sterilization method, software version;
  • □ Prepare the certificate coverage statement: list of waived documents, certificate numbers and validity dates, and the mapping to the declared product;
  • □ Base the project schedule on the current maximum of 30 calendar days (from confirmation of fee payment), treating the draft 10 working days as an upside scenario;
  • □ Organize existing manufacturing inspection reports from the union framework and assess the usability of the at least two member states confirmation (draft status);
  • □ Track the formal publication of the draft amendment and confirm the rollout date of electronic certificates.

Regulatory information verified as of October 29, 2026.

Our services cover: premarket pathway selection and feasibility assessment, registration dossier preparation and submission, authorized representative arrangements, local testing and clinical trial organization, manufacturing site inspection coordination, quality management system compliance support, post-market surveillance and vigilance system setup, import and distribution compliance, fee estimation and project budget management.

GRZAN provides regulatory registration support in Kyrgyzstan for medical device manufacturers, importers and authorized representatives, covering the full pathway from route selection to post-market obligations.

The GRZAN regulatory team consists of professionals with years of hands-on experience in Eurasian Economic Union registrations and maintains a stable local collaboration network in Bishkek, Almaty, Tashkent, Moscow and other cities, working in Chinese, Russian and English. We deliver actionable solutions for the issues foreign manufacturers most often encounter in the CIS region, including authorized representative arrangements, the notarization and legalization chain for powers of attorney, localization of technical documentation, and inspection readiness.

We hold to one principle: every regulatory conclusion we publish must rest on verifiable official sources. Figures and timelines that cannot be verified are labeled as a practical estimate, and experience-based values are never presented as legal requirements.

For project consultation on market access in Kyrgyzstan or the Eurasian Economic Union, contact us at info@grzanglobal.com.

GRZAN | Global Medical Device Regulatory Registration and Compliance Services

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail